|
|||||
|
|
Discovery of new S-adenosylmethionine decarboxylase inhibitors for the treatment of Human African Trypanosomiasis (HAT) |
|
| Authors: | Bradford Hirth Robert H. Barker Cassandra A. Celatka Jeffrey D. Klinger Hanlan Liu Bakela Nare Amarjit Nijjar Margaret A. Phillips Edmund Sybertz Erin K. Willert Yibin Xiang |
| Affiliation: | 1. Drug and Biomaterial R&D, Genzyme Corporation, 153 Second Avenue, Waltham, MA 02451, United States;2. SCYNEXIS, Inc., 3501C Tricenter Boulevard, Durham, NC 27713, United States;3. University of Texas Southwestern Medical Center, Department of Pharmacology, 6001 Forest Park Road, Dallas, TX 75390-9041, United States |
| Abstract: | Modification of the structure of trypanosomal AdoMetDC inhibitor 1 (MDL73811) resulted in the identification of a new inhibitor 7a, which features a methyl substituent at the 8-position. Compound 7a exhibits improved potencies against both the trypanosomal AdoMetDC enzyme and parasites, and better blood brain barrier penetration than 1. |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |